AI-Enabled Drug Discovery and Clinical Trials Market Size, Share, By Offering (Software Solutions and Services), Therapeutic Area (Oncology, Cardiovascular Diseases, Nervous System Diseases, Respiratory Diseases, Infectious Diseases, and Others), Application (Data Aggregation and Analysis, Clinical Trials, Drug Design, Drug Characterization, and Biomarker Research), End-User (Biopharmaceutical Industry, Contract Research Organizations (CROs), Academic and Research Centers, and Others), and Region - Trends, Analysis, and Forecast till 2035

Report Code: PMI429620 | Publish Date: March 2024 | No. of Pages: 168

Global AI Enabled Drug Discovery And Clinical Trials Market Trends

The High Prevalence of Cancer is Propelling the Market Expansion

Since AI technologies can effectively analyze large amounts of cancer data to identify potential drug targets, personalize treatment plans, and accelerate the development of new therapies, the high prevalence of cancer worldwide significantly fuels the growth of the market for AI-enabled drug discovery and clinical trials. This, in turn, leads to faster and more effective cancer drug development.